These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10428675)

  • 1. [Screening for Chlamydia trachomatis infection: which target group and at what price?].
    Postma MJ; van den Hoek JA
    Ned Tijdschr Geneeskd; 1999 Jun; 143(23):1237-8. PubMed ID: 10428675
    [No Abstract]   [Full Text] [Related]  

  • 2. [Screening for Chlamydia trachomatis infection: which group should be targeted and at what price?].
    van Vloten WA
    Ned Tijdschr Geneeskd; 1999 Mar; 143(13):652-3. PubMed ID: 10321294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Screening for asymptomatic Chlamydia trachomatis infection: cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
    Habets PC
    Ned Tijdschr Geneeskd; 2001 Mar; 145(10):499-501. PubMed ID: 11268916
    [No Abstract]   [Full Text] [Related]  

  • 4. [Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population in Amsterdam. III. Cost-effectiveness analysis of screening women and the role of reinfection and partner treatment].
    Postma MJ; Welte R; van den Hoek JA; Jager JC; van Doornum GJ; Coutinho RA
    Ned Tijdschr Geneeskd; 1999 Nov; 143(47):2383-5. PubMed ID: 10590778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
    Ruitenberg EN
    Ned Tijdschr Geneeskd; 1999 May; 143(19):1012. PubMed ID: 10368724
    [No Abstract]   [Full Text] [Related]  

  • 6. The chlamydia problem in New Zealand.
    Perkins N
    N Z Med J; 2004 May; 117(1194):U887. PubMed ID: 15156205
    [No Abstract]   [Full Text] [Related]  

  • 7. [Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
    Postma MJ; Bakker A; Welte R; van Bergen JE; van den Hoek JA; de Jong-van den Berg LT; Jager JC
    Ned Tijdschr Geneeskd; 2000 Dec; 144(49):2350-4. PubMed ID: 11129971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for pharyngeal Chlamydia trachomatis in asymptomatic men who have sex with men.
    Coughlan E; Young S
    N Z Med J; 2006 Apr; 119(1232):U1948. PubMed ID: 16633402
    [No Abstract]   [Full Text] [Related]  

  • 9. Is Europe ready for STD screening?
    Mårdh PA
    Genitourin Med; 1997 Apr; 73(2):96-8. PubMed ID: 9215088
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-effectiveness analysis of screening adolescent males for Chlamydia on admission to detention.
    Blake DR; Gaydos CA; Quinn TC
    Sex Transm Dis; 2004 Feb; 31(2):85-95. PubMed ID: 14743071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Snaring a silent threat. Chlamydia declining thanks to screening and prevention.
    Hobus P
    Adv Nurse Pract; 2002 Oct; 10(10):63-6. PubMed ID: 12424886
    [No Abstract]   [Full Text] [Related]  

  • 12. [The Dutch Health Council report on screening for Chlamydia: too reserved].
    Dekker JH
    Ned Tijdschr Geneeskd; 2005 Apr; 149(16):850-2. PubMed ID: 15868986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.
    Norman JE; Wu O; Twaddle S; Macmillan S; McMillan L; Templeton A; McKenzie H; Noone A; Allardice G; Reid M
    BJOG; 2004 Nov; 111(11):1261-8. PubMed ID: 15521872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Potentials of screening for Chlamydia trachomatis in Hungary: cost-benefit analysis].
    Nyári T; Mészáros G; Deák J; Nagy E; Kovács L
    Orv Hetil; 2000 Jul; 141(27):1511-6. PubMed ID: 10943109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The silent epidemic of Chlamydia: what are we missing here?
    Sanfilippo JS
    J Pediatr Adolesc Gynecol; 2008 Oct; 21(5):231-2. PubMed ID: 18794016
    [No Abstract]   [Full Text] [Related]  

  • 16. [Towards screening for Chlamydia trachomatis].
    Kolmos HJ
    Ugeskr Laeger; 1997 Aug; 159(34):5104-5. PubMed ID: 9297316
    [No Abstract]   [Full Text] [Related]  

  • 17. Chlamydia trachomatis: common misperceptions and misunderstandings.
    Stevens-Simon C; Sheeder J
    J Pediatr Adolesc Gynecol; 2005 Aug; 18(4):231-43. PubMed ID: 16171726
    [No Abstract]   [Full Text] [Related]  

  • 18. Universal screening or prophylactic treatment for Chlamydia trachomatis infection among women seeking induced abortions: which strategy is more cost-effective?
    Chen S; Li J; van den Hoek A
    Sex Transm Dis; 2007 Apr; 34(4):230-6. PubMed ID: 17414068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of costs, effectiveness, and disease control of a population-based program using home sampling for diagnosis of urogenital Chlamydia trachomatis Infections.
    Andersen B; Gundgaard J; Kretzschmar M; Olsen J; Welte R; Oster-Gaard L
    Sex Transm Dis; 2006 Jul; 33(7):407-15. PubMed ID: 16601656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for Chlamydia trachomatis; the Amsterdam experience.
    Bleker OP
    Minerva Ginecol; 2000 Dec; 52(12 Suppl 1):97-9. PubMed ID: 11526697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.